An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesis

被引:4
|
作者
Garcia-Dominguez, Daniel J. [1 ]
Hontecillas-Prieto, Lourdes [1 ]
Andres Leon, Eduardo [2 ]
Sanchez-Molina, Sara [3 ]
Rodriguez-Nunez, Pablo [1 ]
Moron, Francisco J. [4 ]
Hajji, Nabil [5 ]
Mackintosh, Carlos [6 ]
de Alava, Enrique [1 ,7 ]
机构
[1] Univ Seville, Inst Biomed Seville IBiS, Hosp Univ Virgen del Rocio, CIBERONC,CSIC, Seville, Spain
[2] Consejo Super Invest Cient IPBLN CSIC, Bioinformat Unit, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain
[3] Hosp St Joan Deu, Dev Tumor Biol Lab, Inst Recerca Pediat, Barcelona, Spain
[4] Univ Seville, Inst Biomed Sevilla IBiS, Genom Core Facil, Hosp Univ Virgen Rocio,CSIC, Seville, Spain
[5] Imperial Coll London, Div Brain Sci, John Fulcher Mol Neurooncol, London, England
[6] Vitro SA, Granada, Spain
[7] Univ Seville, Sch Med, Dept Normal & Pathol Cytol & Histol, Seville, Spain
来源
PLOS ONE | 2020年 / 15卷 / 06期
关键词
GENE; EWS-FLI1; DIFFERENTIATION; TUMORIGENESIS; HETEROGENEITY; ONCOPROTEIN; REPRESSION; INITIATION; PROGRAM; GROWTH;
D O I
10.1371/journal.pone.0234243
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The presence of the chimeric EWSR1-FLI1 oncoprotein is the main and initiating event defining Ewing sarcoma (ES). The dysregulation of epigenomic and proteomic homeostasis induced by the oncoprotein contributes to a wide variety of events involved in oncogenesis and tumor progression. Attempts at studying the effects of EWSR1-FLI1 in non-tumor cells to understand the mechanisms underlying sarcomagenesis have been unsuccessful to date, as ectopic expression of EWSR1-FLI1 blocks cell cycle progression and induces apoptosis in the tested cell lines. Therefore, it is essential to find a permissive cell type for EWSR1-FLI1 expression that allows its endogenous molecular functions to be studied. Here we have demonstrated that HeLa cell lines are permissive to EWSR1-FLI1 ectopic expression, and that our model substantially recapitulates the endogenous activity of the EWSR1-FLI1 fusion protein. This model could contribute to better understanding ES sarcomagenesis by helping to understand the molecular mechanisms induced by the EWSR1-FLI1 oncoprotein.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Extraskeletal Ewing Sarcoma with EWSR1-FLI1 Fusion Protein
    Suthar, Pokhraj Prakashchandra
    Virmani, Sumeet
    RADIOLOGY-CARDIOTHORACIC IMAGING, 2023, 5 (04):
  • [2] EWSR1-FLI1 Regulates PAX7 Expression in Ewing Sarcoma
    Charville, Gregory
    Wang, Wei-Lien
    Hornick, Jason L.
    de Rijn, Matt van
    Lazar, Alexander J.
    MODERN PATHOLOGY, 2017, 30 : 14A - 14A
  • [3] EWSR1-FLI1 Regulates PAX7 Expression in Ewing Sarcoma
    Charville, Gregory
    Wang, Wei-Lien
    Hornick, Jason L.
    van de Rijn, Matt
    Lazar, Alexander J.
    LABORATORY INVESTIGATION, 2017, 97 : 14A - 14A
  • [4] Therapeutic Potential of EWSR1-FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma
    Cervera, Saint T.
    Rodriguez-Martin, Carlos
    Fernandez-Tabanera, Enrique
    Melero-Fernandez de Mera, Raquel M.
    Morin, Matias
    Fernandez-Penalver, Sergio
    Iranzo-Martinez, Maria
    Amhih-Cardenas, Jorge
    Garcia-Garcia, Laura
    Gonzalez-Gonzalez, Laura
    Angel Moreno-Pelayo, Miguel
    Alonso, Javier
    CANCERS, 2021, 13 (15)
  • [5] Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma
    Garcia-Dominguez, Daniel J.
    Hajji, Nabil
    Sanchez-Molina, Sara
    Figuerola-Bou, Elisabet
    de Pablos, Rocio M.
    Espinosa-Oliva, Ana M.
    Andres-Leon, Eduardo
    Terron-Camero, Laura Carmen
    Flores-Campos, Rocio
    Pascual-Pasto, Guillem
    Robles, Maria Jose
    Carcaboso, Angel M.
    Mora, Jaume
    de Alava, Enrique
    Hontecillas-Prieto, Lourdes
    Machado, Isidro
    Llombart-Bosch, Antonio
    Magagnoli, Giovanna
    Scotlandi, Katia
    ONCOGENE, 2021, 40 (39) : 5843 - 5853
  • [6] Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma
    Daniel J. García-Domínguez
    Nabil Hajji
    Sara Sánchez-Molina
    Elisabet Figuerola-Bou
    Rocío M. de Pablos
    Ana M. Espinosa-Oliva
    Eduardo Andrés-León
    Laura Carmen Terrón-Camero
    Rocío Flores-Campos
    Guillem Pascual-Pasto
    María José Robles
    Isidro Machado
    Antonio Llombart-Bosch
    Giovanna Magagnoli
    Katia Scotlandi
    Ángel M. Carcaboso
    Jaume Mora
    Enrique de Álava
    Lourdes Hontecillas-Prieto
    Oncogene, 2021, 40 : 5843 - 5853
  • [7] Solid endobronchial tumor with EWSR1-FLI1 fusion gene - A diagnostically challenging case of the Ewing sarcoma
    Kirishima, Mari
    Kato, Ikuma
    Hisaoka, Masanori
    Nakatani, Yukio
    Takeda, Aya Harada
    Mizuno, Keiko
    Tanimoto, Akihide
    PATHOLOGY INTERNATIONAL, 2021, 71 (07) : 488 - 490
  • [8] Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53
    van der Ent, Wietske
    Jochemsen, Aart G.
    Teunisse, Amina F. A. S.
    Krens, S. F. Gabriel
    Szuhai, Karoly
    Spaink, Herman P.
    Hogendoorn, Pancras C. W.
    Snaar-Jagalska, B. Ewa
    JOURNAL OF PATHOLOGY, 2014, 233 (04): : 415 - 424
  • [9] EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival
    Gallegos, Zachary R.
    Taus, Patrick
    Gibbs, Zane A.
    McGlynn, Kathleen
    Gomez, Nicholas C.
    Davis, Ian
    Whitehurst, Angelique W.
    MOLECULAR AND CELLULAR BIOLOGY, 2019, 39 (14)
  • [10] RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis
    Sanchez-Molina, Sara
    Figuerola-Bou, Elisabet
    Blanco, Enrique
    Sanchez-Jimenez, Maria
    Taboas, Pablo
    Gomez, Soledad
    Ballare, Cecilia
    Garcia-Dominguez, Daniel J.
    Prada, Estela
    Hontecillas-Prieto, Lourdes
    Carcaboso, Angel M.
    Tirado, Oscar M.
    Hernandez-Munoz, Inmaculada
    de Alava, Enrique
    Lavarino, Cinzia
    Di Croce, Luciano
    Mora, Jaume
    SCIENCE ADVANCES, 2020, 6 (43)